Another monoclonal antibody-based imaging agent from Immunomedicshas been recommended for approval in Europe. The Morris Plains,NJ, company reported last week that its LeukoScan agent for imagingbone infection has received a positive recommendation from
Another monoclonal antibody-based imaging agent from Immunomedics
has been recommended for approval in Europe. The Morris Plains,
NJ, company reported last week that its LeukoScan agent for imaging
bone infection has received a positive recommendation from Europe's
Committee for Proprietary Medicinal Products. The company's CEA-Scan
product was cleared in Europe earlier this month (SCAN 10/9/96).
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.